Hsbc Holdings PLC Sells 8,305 Shares of MeiraGTx Holdings PLC $MGTX

Hsbc Holdings PLC trimmed its holdings in MeiraGTx Holdings PLC (NASDAQ:MGTX) by 31.1% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,410 shares of the company’s stock after selling 8,305 shares during the period. Hsbc Holdings PLC’s holdings in MeiraGTx were worth $125,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in MGTX. GAMMA Investing LLC lifted its stake in shares of MeiraGTx by 3,606.7% in the first quarter. GAMMA Investing LLC now owns 4,448 shares of the company’s stock worth $30,000 after buying an additional 4,328 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in shares of MeiraGTx by 68.1% in the fourth quarter. Tower Research Capital LLC TRC now owns 4,975 shares of the company’s stock worth $30,000 after buying an additional 2,016 shares during the last quarter. CWM LLC lifted its stake in shares of MeiraGTx by 1,737.7% in the first quarter. CWM LLC now owns 8,674 shares of the company’s stock worth $59,000 after buying an additional 8,202 shares during the last quarter. ProShare Advisors LLC lifted its stake in shares of MeiraGTx by 41.2% in the fourth quarter. ProShare Advisors LLC now owns 16,814 shares of the company’s stock worth $102,000 after buying an additional 4,910 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its stake in shares of MeiraGTx by 41.4% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 17,976 shares of the company’s stock worth $110,000 after buying an additional 5,259 shares during the last quarter. 67.48% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

MGTX has been the subject of a number of analyst reports. Chardan Capital restated a “buy” rating and issued a $35.00 price objective on shares of MeiraGTx in a research note on Friday, August 15th. Wall Street Zen upgraded shares of MeiraGTx from a “sell” rating to a “hold” rating in a research note on Saturday, July 5th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $24.00.

MeiraGTx Price Performance

NASDAQ:MGTX opened at $7.69 on Friday. The stock has a market cap of $618.64 million, a P/E ratio of -3.77 and a beta of 1.29. MeiraGTx Holdings PLC has a one year low of $3.86 and a one year high of $8.98. The company has a fifty day moving average price of $7.89 and a 200 day moving average price of $6.82. The company has a debt-to-equity ratio of 26.29, a current ratio of 0.88 and a quick ratio of 0.88.

MeiraGTx (NASDAQ:MGTX) last released its earnings results on Thursday, August 14th. The company reported ($0.48) EPS for the quarter, beating the consensus estimate of ($0.52) by $0.04. The firm had revenue of $3.69 million during the quarter, compared to analysts’ expectations of $8.00 million. MeiraGTx had a negative net margin of 415.39% and a negative return on equity of 314.44%. Analysts anticipate that MeiraGTx Holdings PLC will post -1.48 earnings per share for the current year.

Insider Buying and Selling at MeiraGTx

In other MeiraGTx news, CFO Richard Giroux sold 24,000 shares of the business’s stock in a transaction on Tuesday, July 22nd. The shares were sold at an average price of $8.52, for a total value of $204,480.00. Following the sale, the chief financial officer owned 853,494 shares of the company’s stock, valued at $7,271,768.88. The trade was a 2.74% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Alexandria Forbes sold 47,500 shares of the business’s stock in a transaction on Tuesday, July 8th. The shares were sold at an average price of $7.97, for a total transaction of $378,575.00. Following the completion of the sale, the chief executive officer directly owned 1,361,483 shares in the company, valued at $10,851,019.51. This trade represents a 3.37% decrease in their position. The disclosure for this sale can be found here. Insiders own 7.50% of the company’s stock.

About MeiraGTx

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.